The expanded indication makes risankizumab the first IL-23 inhibitor available for pediatric patients weighing under 40kg with plaque psoriasis or psoriatic arthritis, supported by phase 3 OptIMMize ...
Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a ...
The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active ...
The FDA approved Zoryve cream 0.3% for the treatment of plaque psoriasis in children as young as 2 years, Arcutis announced ...
The FDA has approved an expanded indication for Zoryve (roflumilast) cream 0.3% to include plaque psoriasis in pediatric patients aged 2 years and older.
Whether children receive an opioid prescription after surgery varies substantially by procedure type and hospital, according to a new national analysis published in the Journal of the American College ...
Prescription rates for attention-deficit/hyperactivity disorder medications are rising sharply in Poland, with the fastest increases seen among young adults, particularly women.
Iron deficiency anemia happens when your body doesn’t have enough iron to make red blood cells, reducing oxygen flow to organs and tissues. This affects about 25% of people worldwide. Oral iron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results